In a market dominated by billion-dollar data giants, SharePath is quietly proving that pharma's real problem isn't data—it's delivery. With just 5 employees and zero institutional funding, they're generating $600K by targeting the 'last-mile' gap that giants like IQVIA and Symphony Health ignore.

"They're not selling data—they're selling action. That's the only metric that matters in pharma commercialization."

The zero-traffic website is the most telling data point. SharePath isn't playing the inbound marketing game—they're likely built on referral networks and direct relationships. In pharma, where trust and compliance trump SEO, this isn't a bug; it's a feature. Their 'Where Rx's Begin' tagline hints at a bottom-funnel focus that bypasses the awareness theater entirely.

• Bootstrapped discipline: $0.6M on 5 people means no burn rate pressure
• Last-mile specificity: They own the gap between data and action
• Relationship-driven: Zero web traffic suggests high-touch B2B sales
• Stack pragmatism: WordPress + Tailwind = fast iteration, low overhead